Page 7 - Amrx News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Amrx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Amrx Today - Breaking & Trending Today
The process of acquiring a company or finding a great buyer for your company can be intimidating. There are many different options and avenues to consider. ....
Amneal Pharmaceuticals (NYSE:AMRX – Free Report) had its price target raised by Piper Sandler from $3.00 to $5.00 in a research note published on Monday, MarketBeat Ratings reports. Piper Sandler currently has an overweight rating on the stock. AMRX has been the subject of a number of other reports. Barclays boosted their target price on […] ....
Amneal Pharmaceuticals (NYSE:AMRX – Free Report) had its price objective upped by Piper Sandler from $3.00 to $5.00 in a report published on Monday morning, Marketbeat.com reports. They currently have an overweight rating on the stock. Other equities analysts have also recently issued reports about the company. 500.com reissued a maintains rating on shares of […] ....
Amneal Pharmaceuticals (NYSE:AMRX – Get Free Report) had its price objective boosted by analysts at Truist Financial from $4.00 to $6.00 in a research note issued to investors on Monday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Truist Financial’s price target points to a potential upside of 42.01% from the […] ....
Amneal Pharmaceuticals (NYSE:AMRX – Get Free Report) updated its FY 2023 earnings guidance on Friday. The company provided earnings per share guidance of $0.45-$0.55 for the period, compared to the consensus earnings per share estimate of $0.47. The company issued revenue guidance of $2.30 billion-$2.40 billion, compared to the consensus revenue estimate of $2.32 billion. […] ....